Making Maintenance a True Asset in Pharma Manufacturing through Digitalization

Learning Level: Beginner/Intermediate
Session Length: 1 hour

Did you know that more than 80% of equipment failures in manufacturing are caused by human error or adverse operating conditions rather than time-based wear and tear? That’s why pharma companies are increasingly progressing their digital journey beyond computerized maintenance management systems (CMMS) to embrace AI-powered predictive and prescriptive maintenance that prevents unplanned downtime and increases overall productivity.

Join experts Constantino Rodriguez, Director of Engineering at Minaris Regenerative Medicine and co-chair of the ISPE Maintenance Good Practice Guide and Monica Lomeli, Pharma Principal Solution Consultant at Aspen Technology as they discuss new opportunities created by a digital asset performance management (APM) strategy.

Learning Objective

  • Avoid the pain and cost of lost production resulting from unplanned downtime
  • Predict equipment failures up to weeks in advance and plan maintenance proactively to minimize schedule disruptions
  • Protect entire sites via AI-powered predictive maintenance that readily scales across similar equipment
  • Reduce costs by avoiding calendar-based maintenance interventions when they are not needed

Register today to hear how you can quickly advance from conventional to predictive and prescriptive maintenance, optimizing the effectiveness of equipment reliability programs without compromising adherence to applicable regulatory requirements.

Download Presentation


Monica Lomeli
Principal Solution Consultant, Pharmaceutical Business Unit
Aspen Technology
Constantino Rodriguez
Director, Engineering
Minaris Regenerative Medicine C&GT

Copyright Disclaimer

This copyright notice applies to all proprietary pages, images, text, programs, and other material available throughout this Internet site (collectively, this “Publication”). All materials posted on the website are subject to copyrights owned by the International Society for Pharmaceutical Engineering (“ISPE”) and other individuals or entities. Any reproduction, retransmission or republication of all or part of any documents found on this site is expressly prohibited, unless ISPE or the copyright owner of the material has expressly granted its prior written consent to reproduce, retransmit or republish the material. All other rights reserved. View entire copyright policy.

Subscribe to your ISPE YouTube Channel
& Click the bell for notifications.

View All Videos